id
related bits
0
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
27 (unknown)
first seen date
2024-07-07 23:20:36
expired found date
-
created at
2024-07-07 23:20:36
updated at
2026-02-19 14:44:58
length
31
crc
18980
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
3
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
2026-03-05 14:45:15
server bits
NGINX
AMAZONS3
server ip
mp import status
27
mp rejected date
-
mp saved date
-
mp size orig
142129
mp size raw text
7689
mp inner links count
0
mp inner links status
1 (no links)
title
PROVENGE® (sipuleucel-T)
description
What is metastatic castration-resistant prostate cancer? Metastatic castration-resistant prostate cancer (mCRPC) is a form of advanced prostate cancer.
site name
PROVENGE (sipuleucel-T)
author
updated
2026-03-06 00:22:58
raw text
PROVENGE® (sipuleucel-T) Skip to content PROVENGE (sipuleucel-T) Main Menu Advanced Prostate Cancer Show submenu mCRPC Immunotherapy Your PROVENGE Journey Resources Coverage & Patient Support About PROVENGE Important Safety Information Full Prescribing Information Download a Brochure Find A Doctor Attend an Event For HCPs Search Advanced Prostate Cancer Show submenu mCRPC Immunotherapy Your PROVENGE Journey Resources Coverage & Patient Support About PROVENGE Learn more about PROVENGE Immunotherapy For Advanced Prostate Cancer It’s About MORE TIME PROVENGE is a personalized immunotherapy that activates the immune system to help fight advanced prostate cancer and has been proven to help certain men with metastatic castration-resistant prostate cancer (mCRPC) live longer. Learn more about PROVENGE Learn more about PROVENGE What is metastatic castration-resistant prostate cancer? Metastatic castration-resistant prostate...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
1
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
6167
text words
1139
text unique words
427
text lines
113
text sentences
52
text paragraphs
20
text words per sentence
21
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
0
links other domains
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
0
links ext klim
0
links ext generic
1
dol status
0
dol updated
2026-03-06 00:22:58
rss path
rss status
0 (new)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
0 (new)
sitemap review version
2
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
-
sitemap first import date
-
sitemap last import date
-